Literature DB >> 2749111

The clinical pathology of Crimean-Congo hemorrhagic fever.

R Swanepoel1, D E Gill, A J Shepherd, P A Leman, J H Mynhardt, S Harvey.   

Abstract

Observations were made of 15 fatal and 35 nonfatal Crimean-Congo hemorrhagic fever (CCHF) infections diagnosed from February 1981 to March 1987 in Kimberly and Sandringham, Republic of South Africa. Following an incubation period of 2-9 days after exposure to infection, patients had a sudden onset of disease with fever, nausea, severe headache, and myalgia. Petechial rash and hemorrhagic signs such as epistaxis, hematemesis, and melena supervened on days 3-6 of illness. Deaths occurred on days 5-14 of illness. Patients with fatal infections had thrombocytopenia and markedly elevated levels of serum aspartate and alanine aminotransaminases, gamma-glutamyltransferase, lactic dehydrogenase, creatine kinase, bilirubin, creatinine, and urea. Total protein, albumin, fibrinogen, and hemoglobin levels were depressed. Values for prothrombin ratio, activated partial thromboplastin time, thrombin time, and fibrin degradation products were grossly elevated, findings that indicate the occurrence of disseminated intravascular coagulopathy. Many of the clinical pathologic changes were evident at an early stage of the disease and had a highly predictive value for fatal outcome of infection. Changes were present but less marked in nonfatal infections.

Entities:  

Mesh:

Year:  1989        PMID: 2749111     DOI: 10.1093/clinids/11.supplement_4.s794

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  76 in total

1.  Reverse genetics for crimean-congo hemorrhagic fever virus.

Authors:  Ramon Flick; Kirsten Flick; Heinz Feldmann; Fredrik Elgh
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model.

Authors:  Cong Jin; Mifang Liang; Junyu Ning; Wen Gu; Hong Jiang; Wei Wu; Fushun Zhang; Chuan Li; Quanfu Zhang; Hua Zhu; Ting Chen; Ying Han; Weilun Zhang; Shuo Zhang; Qin Wang; Lina Sun; Qinzhi Liu; Jiandong Li; Tao Wang; Qiang Wei; Shiwen Wang; Ying Deng; Chuan Qin; Dexin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

3.  Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.

Authors:  Hüseyin Can Hekimoğlu; Neşe Ateş Demirci
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

4.  An unusual intracerebral hemorrhage.

Authors:  Roya Alavi-Naini; Ali Moghtaderi; Malyhe Metanat
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-05       Impact factor: 2.471

5.  Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus.

Authors:  Roman Wölfel; Janusz T Paweska; Nadine Petersen; Antoinette A Grobbelaar; Patricia A Leman; Roger Hewson; Marie-Claude Georges-Courbot; Anna Papa; Volker Heiser; Marcus Panning; Stephan Günther; Christian Drosten
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

6.  Alterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic fever.

Authors:  Elif Bilge Uysal; Enver Sancakdar; Ayşe Şeker; Köksal Deveci; Nevin Tuzcu; Hekim Karapınar
Journal:  Int J Clin Exp Med       Date:  2015-02-15

7.  Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever.

Authors:  Enver Sancakdar; Ahmet Sami Güven; Elif Bilge Uysal; Ali Kaya; Köksal Deveci; Hekim Karapınar; Ismail Akkar
Journal:  Int J Clin Exp Med       Date:  2014-03-15

8.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

9.  Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever.

Authors:  Ismail Sari; Sevtap Bakir; Aynur Engin; Hüseyin Aydin; Omer Poyraz
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

10.  Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia.

Authors:  Anna Papa; Bojana Bozovi; Vassiliki Pavlidou; Evangelia Papadimitriou; Mijomir Pelemis; Aantonis Antoniadis
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.